CRIS Current Research Information System

PALMERINI, EMANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.371
AS - Asia 8.315
EU - Europa 5.808
SA - Sud America 539
AF - Africa 419
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 10
Totale 24.491
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.251
VN - Vietnam 2.485
SG - Singapore 2.350
CN - Cina 1.634
GB - Regno Unito 1.271
IT - Italia 1.030
DE - Germania 919
HK - Hong Kong 772
SE - Svezia 663
BR - Brasile 396
FR - Francia 396
IN - India 383
RU - Federazione Russa 317
IE - Irlanda 239
NL - Olanda 161
JP - Giappone 160
FI - Finlandia 138
ZA - Sudafrica 138
KR - Corea 112
UA - Ucraina 109
CH - Svizzera 103
EE - Estonia 95
CI - Costa d'Avorio 94
ES - Italia 81
TG - Togo 79
JO - Giordania 67
AT - Austria 65
BG - Bulgaria 60
CA - Canada 56
BD - Bangladesh 54
AR - Argentina 52
PH - Filippine 50
ID - Indonesia 43
BE - Belgio 42
TH - Thailandia 42
PL - Polonia 40
IQ - Iraq 32
EC - Ecuador 30
MX - Messico 28
AU - Australia 24
MA - Marocco 24
EG - Egitto 23
CO - Colombia 16
SC - Seychelles 16
GR - Grecia 15
MY - Malesia 15
PK - Pakistan 14
SA - Arabia Saudita 13
TR - Turchia 13
TW - Taiwan 12
UZ - Uzbekistan 12
CL - Cile 11
ET - Etiopia 10
RO - Romania 10
KE - Kenya 9
AL - Albania 8
LB - Libano 8
PY - Paraguay 8
BZ - Belize 7
IR - Iran 7
NO - Norvegia 7
PE - Perù 7
UY - Uruguay 7
VE - Venezuela 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
LT - Lituania 6
NG - Nigeria 6
A2 - ???statistics.table.value.countryCode.A2??? 5
HU - Ungheria 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
KW - Kuwait 4
SY - Repubblica araba siriana 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
LV - Lettonia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
FJ - Figi 2
GA - Gabon 2
KZ - Kazakistan 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 24.460
Salva come PNG Salva come JPEG
Città #
Singapore 1.622
Southend 1.104
Ashburn 1.010
Fairfield 861
Chandler 761
Hong Kong 744
San Jose 645
Ho Chi Minh City 566
Hanoi 552
Woodbridge 463
Wilmington 416
Seattle 371
Santa Clara 367
Houston 347
Ann Arbor 346
Princeton 332
Cambridge 292
Beijing 267
Dong Ket 261
Dublin 238
Boardman 221
Lauterbourg 164
Frankfurt am Main 163
Hefei 146
Bologna 144
Tokyo 132
Los Angeles 121
Helsinki 115
Nanjing 113
Westminster 110
Padova 104
Abidjan 94
Buffalo 91
Seoul 90
Bern 86
Lomé 79
New York 79
Turin 79
Berlin 78
Dallas 75
Da Nang 73
Redmond 69
Milan 68
Amman 66
Council Bluffs 66
Haiphong 62
Redondo Beach 61
San Diego 60
Saint Petersburg 58
Bremen 57
Sofia 52
Medford 48
Shenyang 47
Des Moines 45
São Paulo 45
Falls Church 43
Jinan 43
Munich 43
Rome 42
Brussels 40
Guangzhou 40
Dearborn 39
Shanghai 39
Hebei 38
Chicago 36
Vienna 35
Nanchang 34
Changsha 32
Hải Dương 28
Düsseldorf 27
Nuremberg 27
Biên Hòa 26
Jacksonville 26
Falkenstein 25
Amsterdam 24
Atlanta 24
Can Tho 24
Quận Bình Thạnh 24
Zhengzhou 23
Lacchiarella 22
London 22
Orem 22
San Francisco 22
Hangzhou 21
Norwalk 21
Warsaw 21
Paris 20
Phoenix 20
Thái Nguyên 20
Tianjin 20
Cairo 19
Ha Long 19
Jiaxing 19
Florence 17
Bengaluru 16
Jakarta 16
Redwood City 16
Wuhan 16
Bari 15
Brooklyn 15
Totale 15.907
Salva come PNG Salva come JPEG
Nome #
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 460
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 355
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 315
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 306
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 281
Abstract 5909: IDH mutations in G2-3 conventional chondrosarcoma of bone: a mono institutional experience 274
A Mass with High Uptake of Fluorodeoxyglucose on Positron Emission Tomography 260
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy 250
Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response? 233
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β 229
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: A single-institution morphological and molecular analysis of seven cases 228
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study 222
Delaying surgery for patients with a previous SARS-CoV-2 infection 216
Toxicity and efficacy of busulfan-melphalan (BuMel) compared to treosulfan-melphalan (TreoMel) high dose chemotherapy (HDCT) consolidation in high-risk Ewing sarcoma (ES): A 12-year monoinstitutional experience 213
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 212
Predictive factors of histologic response to primary chemotherapy in patients with ewing sarcoma 205
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone 205
Osteosarcoma follow-up: chest X-ray or computed tomography? 199
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? 198
SELNET clinical practice guidelines for soft tissue sarcoma and GIST 198
Advances in treatment for tenosynovial giant cell tumors 196
CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338 196
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. 195
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 193
Case report: temozolomide induced partial response in a primary diffuse leptomeningeal gliomatosis patient. 192
Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma 189
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study 188
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 187
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors 187
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age 185
Pazopanib in relapsed osteosarcoma patients: report on 15 cases 184
Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution 184
Chondrosarcomas revisited. 183
Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? 180
Diagnosis and prognosis for the Ewing family of tumors 180
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma 176
Eribulin in advanced liposarcoma and leiomyosarcoma 174
Advanced chondrosarcomas: Role of chemotherapy and survival 174
ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2) 174
Tenosynovial giant cell tumor (TGCT)/pigmented villonodular synovitis (PVNS): Outcome of 313 patients before the era of kinase inhibitors 172
A simple prognostic scoring system for non metastatic osteosarcoma of the extremity 171
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients 171
Emerging therapeutic targets for synovial sarcoma 169
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs 166
Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma 166
Extraskeletal myxoid chondrosarcoma: A retrospective analysis of 69 patients with localized disease and molecularly confirmed diagnosis. 165
High dose ifosfamide in metastatic high-grade osteosarcoma, after failure of standard multimodal chemotherapy. 165
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of Soft Tissue and Bone: Clinicopthologic and Molecular Analysis from a Single Institution 165
Whole lung irradiation after high‐dose busulfan/melphalan in ewing sarcoma with lung metastases: An Italian sarcoma group and associazione Italiana ematologia oncologia pediatrica joint study 165
Phase ii study on lapatinib in advanced egfr-positive chordoma 163
Synovial sarcoma: Is chemotaxis important to tumor progression? 162
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: A non-randomised phase 2 clinical trial 162
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence. 161
A nonrandomized phase II trial of sorafenib (S) and everolimus (E) in unresectable metastatic osteosarcoma (OST) patients (pts) relapsed after standard chemotherapy. 160
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study 160
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 159
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 159
Spontaneous regression of lung metastasis from osteosarcoma: A case report 158
Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) 158
High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. 157
Irinotecan and temozolomide upfront and in relapsed Ewing sarcoma: A translational study on MGMT (O6-methylguanine–DNA methyltransferase) and ABCG2 (MGMTLiberati) 156
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 154
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 154
Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma 153
The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the italian Rizzoli experience. Impact on the future. 153
Osteosarcoma of the pelvis: A monoinstitutional experience in patients younger than 41 years 152
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma? 152
Periosteal osteosarcoma: a single-institution experience. 150
Osteosarcoma of the pelvis and sacrum: A retrospective analysis of 73 patients. 150
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ 150
A four-arm randomized phase II trial with NGR-hTNF given at low or high dose with or without doxorubicin in soft tissue sarcomas (STS). 148
Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study 148
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade 147
The natural history of advanced inoperable central chondrosarcoma 146
Analysis of risk factors for central venous catheter-related complications: a prospective observational study in pediatric patients with bone sarcomas 146
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 146
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience 145
Non-surgical treatment of chondrosarcoma: Current concepts and future perspectives 145
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 143
Long-term treatment of giant cell tumors of bone (GCTB) with denosumab: a two institutions 8-year experience. 142
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian Sarcoma Group Trial ISG/OS-1 142
Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution 142
Pazopanib in metastatic osteosarcoma patients: Report of 9 cases treated off label at Rizzoli Orthopedic Institute 142
Metastatic spread to bone: The role of chemotherapy 141
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients 140
Neoadjuvant denosumab treatment of locally advanced giant cell tumor of bone (GCTB). 140
Two doses of NGR-hTNF (N) given alone or in combination with doxorubicin (D) in soft tissue sarcomas (STS). 139
Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma 139
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 139
Temozolamide and irinotecan in metastatic Ewing sarcoma: An Italian Sarcoma Group and Royal Marsden Hospital join study. 138
Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution 137
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 137
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial 137
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: Results of a retrospective multi-institutional case series. 135
miR-494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene 134
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 132
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. 132
Lapatinib in advanced chordoma: A phase II study. 132
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma 131
Palliative embolisation for advanced bone sarcomas. 131
Totale 17.730
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021649 0 0 0 0 0 0 0 0 0 0 82 567
2021/20222.826 231 70 166 150 326 160 68 251 164 223 489 528
2022/20233.336 356 470 247 423 225 238 121 188 525 125 207 211
2023/2024792 51 154 65 65 48 91 56 50 25 62 44 81
2024/20253.577 154 608 273 245 582 179 205 94 67 224 131 815
2025/20268.534 855 876 647 539 880 584 1.005 544 1.779 647 178 0
Totale 24.980